Evidence map›Paper›PMID 28077413›Full record

ArticleBMJ open2017

Cancer-related hospitalisations and 'unknown' stage prostate cancer: a population-based record linkage study.

Qingwei Luo, Xue Qin Yu, David Paul Smith, David Eamon Goldsbury, Claire Cooke-Yarborough, Manish Indravadan Patel, Dianne Lesley O'Connell

Abstract read
In one paragraph

Article in BMJ open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qingwei LuoCancer Research Division, Cancer Council NSW, Sydney, New South Wales, Australia.ORCID 0000-0002-8902-6869
Xue Qin YuCancer Research Division, Cancer Council NSW, Sydney, New South Wales, Australia.
David Paul SmithCancer Research Division, Cancer Council NSW, Sydney, New South Wales, Australia.
David Eamon GoldsburyCancer Research Division, Cancer Council NSW, Sydney, New South Wales, Australia.
Claire Cooke-YarboroughNew South Wales Cancer Registry, Cancer Institute NSW, Sydney, New South Wales, Australia.
Manish Indravadan PatelDiscipline of Surgery, University of Sydney, Sydney, New South Wales, Australia.
Dianne Lesley O'ConnellCancer Research Division, Cancer Council NSW, Sydney, New South Wales, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo identify reasons for prostate cancer stage being recorded as 'unknown' in Australia's largest population-based cancer registry.

designProspective population-based cohort.

settingNew South Wales (NSW) is the most populous state in Australia, with almost one third of the total national population.

participantsNSW Cancer Registry (NSWCR) records for prostate cancer cases diagnosed in 2001-2009 were linked to the NSW Admitted Patient Data Collection (APDC) for 2000-2010. All patients in this study had a minimum of 12 months follow-up in the hospital episode records after their date of diagnosis as recorded by the NSWCR.

main outcome measuresIncidence of 'unknown' stage prostate cancer and cancer-specific survival.

resultsOf 50 597 prostate cancer cases, 39.9% were recorded as having 'unknown' stage. Up to 4 months after diagnosis, 77.2% of cases without a hospital-reported cancer diagnosis were recorded as having 'unknown' stage. Among those patients with a hospital-reported cancer diagnosis, stage was 'unknown' for 7.6% of cases who received a radical prostatectomy (RP) and for 34.0% of cases who had procedures other than RP. In the latter group, the factors that were related to having 'unknown' stage were living in disadvantaged areas (adjusted OR (aOR) range: 1.13 to 1.20), attending a private hospital (aOR range: 1.25 to 2.13), having day-only admission for care (aOR=1.23, 95% CI 1.11 to 1.36), or having procedures other than multiple procedures with imaging (eg, biopsy only, aOR range: 1.11 to 1.45).

conclusionsOver half of 'unknown' stage prostate cancer cases did not have a hospital-reported prostate cancer diagnosis within the 4 months after initial diagnosis. We identified differences in the likelihood of cases being recorded as 'unknown' stage based on socioeconomic status and facility type, which suggests that further investigation of reporting practices in relation to diagnostic and treatment pathways is required.

Indexed as

Medical Record LinkageFollow-Up StudiesHumansIncidenceInformation Storage and RetrievalMaleMiddle AgedNeoplasm StagingNew South WalesPrognosisProspective StudiesProstatic NeoplasmsRegistriesdata linkagehealth servicepopulation-based cancer registryprostate cancersocio-economic statusunknown stage at diagnosis

Identifiers

PMID28077413
PMCPMC5253597

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.